1
INTRODUCTION SIMULATING COLONIC SURVIVAL OF PROBIOTICS IN SINGLE STRAIN PRODUCTS AS COMPARED TO MULTI-STRAIN PRODUCTS The human gastrointestinal tract contains variety of microbes which may affect the survival of probiotics in a different way. Commercially, multi-strain preparations have been suggested to express an improved functionality over single strain cultures. However, probiotics are often tested as single strains. The aim of this study was to evaluate in an in vitro colon simulation, if the combination of several probiotic strains (HOWARU Restore; Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium lactis Bl-04 and B. lactis Bi-07) had an influence on each other’s survival as compared to the strains as single preparations. Figure 1. Illustration of one simulation unit with four sequentially connected glass vessels (V1-V4) mimicking human colon from proximal to distal part. Synthetic ileal fluid as a simulation media, pH controlled, anaerobic conditions at 37 °C. The information contained herein is based on data known to DuPont or its affiliates at the time of preparation of the information and believed by them to be reliable. This is business-to-business information intended for food, beverage and supplement producers, and is not intended for the final consumer of a finished food, beverage or supplement product. The information is provided “as is” and its use is at the recipient’s sole discretion and risk. It is the recipient’s sole responsibility to determine the suitability and legality of its proposed use of DuPont products for its specific purposes. Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of DuPont or others. DUPONT HEREBY EXPRESSLY DISCLAIMS (I) ANY AND ALL LIABILITY IN CONNECTION WITH SUCH INFORMATION, INCLUDING, BUT NOT LIMITED TO, ANY LIABILITY RELATING TO THE ACCURACY, COMPLETENESS, OR USEFULNESS OF SUCH INFORMATION, AND (II) ANY AND ALL REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, WITH RESPECT TO SUCH INFORMATION, OR ANY PART THEREOF, INCLUDING ALL REPRESENTATIONS AND WARRANTIES OF TITLE, NONINFRINGEMENT OF COPYRIGHT OR PATENT RIGHTS OF OTHERS, MERCHANTABILITY, FITNESS OR SUITABILITY FOR ANY PURPOSE, AND WARRANTIES ARISING BY LAW, STATUTE, USAGE OF TRADE OR COURSE OF DEALING. Copyright © 2017 DuPont or its affiliates. All Rights Reserved. The DuPont Oval Logo, DuPont™, The miracles of science™ and all products denoted with ® or ™ are registered trademarks or trademarks of E.I. du Pont de Nemours and Company or its affiliated companies. S. Forssten*, K. M. Salli*, A.C. Ouwehand* * DuPont Nutrition & Health Global Health & Nutrition Science Sokeritehtaantie 20 02460 KANTVIK, FINLAND E-mail: [email protected] * * * * * * * * * * * 0 1 2 3 4 5 6 7 8 9 10 Lactobacillus spp Lactobacillus acidophilus Lactobacillus paracasei Bifidobacterium spp. B. lactis BL-04 B. lactis Bi-07 log10 per ml Restore NCFM BL-04 Bi-07 NCFM+BL-04 Lpc-37 CTRL MATERIALS & METHODS RESULTS CONCLUSIONS The in vitro colon simulations of multi-strain and single strain probiotics were performed as previously described (Ref.1, Fig. 1). The control (CTRL) represents the same synthetic ileal medium used for feeding the simulator but without freeze-dried bacteria. DNA was extracted and the quantities of probiotic strains were determined by qPCR. All strains could be detected after the colon simulations to which they had been fed (Fig 2). There were no substantial differences in levels of the same strain when comparing single and multi-strain products. Probiotics do not have an antagonistic effect upon each other’s survival when in a multi-strain product compared to a single-strain product. References: 1, Mäkeläinen H, Olli K, Forssten S, Granlund L, Rautonen N, Ouwehand AC. Probiotic lactobacilli in a semi-soft cheese survive in the simulated human gastrointestinal tract. Int Dairy J. 2009(19):675-83. Figure 2. Microbial quantities presented as mean ± SEM for the pooled vessels (V1-V4) from three separate colon simulations. X-axis represents the analysed species or strains, while the quantity is expressed as log10 copies per ml. Statistical differences marked for treatment vs con- trol as *p<0.05 (students t-test).

Simulating colonic survival of probiotics in single strain products as compared to multi-strain products | Probiota 2017

Embed Size (px)

Citation preview

Page 1: Simulating colonic survival of probiotics in single strain products as compared to multi-strain products | Probiota 2017

INTRODUCTION

SIMULATING COLONIC SURVIVAL OF PROBIOTICS IN SINGLE STRAIN PRODUCTS AS COMPARED TO MULTI-STRAIN PRODUCTS

The human gastrointestinal tract contains variety of microbes which may affect the survival of probiotics in a different way. Commercially, multi-strain preparations have been suggested to express an improved functionality over single strain cultures. However, probiotics are often tested as single strains. The aim of this study was to evaluate in an in vitro colon simulation, if the combination of several probiotic strains (HOWARU Restore; Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium lactis Bl-04 and B. lactis Bi-07) had an influence on each other’s survival as compared to the strains as single preparations.

Figure 1. Illustration of one simulation unit with four sequentially connected glass vessels (V1-V4) mimicking human colon from proximal to distal part. Synthetic ileal fluid as a simulation media, pH controlled, anaerobic conditions at 37 °C.

The information contained herein is based on data known to DuPont or its affiliates at the time of preparation of the information and believed by them to be reliable. This is business-to-business information intended for food, beverage and supplement producers, and is not intended for the final consumer of a finished food, beverage or supplement product. The information is provided “as is” and its use is at the recipient’s sole discretion and risk. It is the recipient’s sole responsibility to determine the suitability and legality of its proposed use of DuPont products for its specific purposes. Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of DuPont or others. DUPONT HEREBY EXPRESSLY DISCLAIMS (I) ANY AND ALL LIABILITY IN CONNECTION WITH SUCH INFORMATION, INCLUDING, BUT NOT LIMITED TO, ANY LIABILITY RELATING TO THE ACCURACY, COMPLETENESS, OR USEFULNESS OF SUCH INFORMATION, AND (II) ANY AND ALL REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, WITH RESPECT TO SUCH INFORMATION, OR ANY PART THEREOF, INCLUDING ALL REPRESENTATIONS AND WARRANTIES OF TITLE, NONINFRINGEMENT OF COPYRIGHT OR PATENT RIGHTS OF OTHERS, MERCHANTABILITY, FITNESS OR SUITABILITY FOR ANY PURPOSE, AND WARRANTIES ARISING BY LAW, STATUTE, USAGE OF TRADE OR COURSE OF DEALING.

Copyright © 2017 DuPont or its affiliates. All Rights Reserved. The DuPont Oval Logo, DuPont™, The miracles of science™ and all products denoted with ® or ™ are registered trademarks or trademarks of E.I. du Pont de Nemours and Company or its affiliated companies.

S. Forssten*, K. M. Salli*, A.C. Ouwehand*

* DuPont Nutrition & HealthGlobal Health & Nutrition ScienceSokeritehtaantie 2002460 KANTVIK, FINLANDE-mail: [email protected]

**

*

*

**

*

**

*

*

0

1

2

3

4

5

6

7

8

9

10

Lactobacillus sppLactobacillus acidophilus

Lactobacillus paracaseiBifidobacterium spp.

B. lactis BL-04B. lactis Bi-07

log1

0 pe

r ml

Restore NCFM BL-04 Bi-07 NCFM+BL-04 Lpc-37 CTRL

MATERIALS & METHODS

RESULTS

CONCLUSIONS

The in vitro colon simulations of multi-strain and single strain probiotics were performed as previously described (Ref.1, Fig. 1). The control (CTRL) represents the same synthetic ileal medium used for feeding the simulator but without freeze-dried bacteria. DNA was extracted and the quantities of probiotic strains were determined by qPCR.

All strains could be detected after the colon simulations to which they had been fed (Fig 2). There were no substantial differences in levels of the same strain when comparing single and multi-strain products.

Probiotics do not have an antagonistic effect upon each other’s survival when in a multi-strain product compared to a single-strain product. References: 1, Mäkeläinen H, Olli K, Forssten S, Granlund L, Rautonen N, Ouwehand AC. Probiotic lactobacilli in a semi-soft

cheese survive in the simulated human gastrointestinal tract. Int Dairy J. 2009(19):675-83.

Figure 2. Microbial quantities presented as mean ± SEM for the pooled vessels (V1-V4) from three separate colon simulations. X-axis represents the analysed species or strains, while the quantity is expressed as log10 copies per ml. Statistical differences marked for treatment vs con-trol as *p<0.05 (students t-test).